StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3084% below fair value
$3.01−0.23 (-7.10%)

Close on Nov 13, 2026Market cap $51.62MP/E –Yield –

Tonix Pharmaceuticals statistics

79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 12, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$51.62M
$272.32M
Enterprise Value
-$111.17M
$146.23M
PS Ratio
1.20
3.66
PB Ratio
0.26
2.00
P/TBV Ratio
0.26
2.22

Enterprise valuationIndustry

EV / Sales
-2.58
2.57

Share statisticsIndustry

Shares Change (QoQ)
14.0%
0.50%
Float
17M
49M
Shares Held by Insiders
0.27%
11.7%
Shares Held by Institutions
54.6%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
12.8%
-0.80%
Short % of Float
19.4%
9.01%
Short % of Shares Outstanding
19.3%
6.30%
Days to Cover
4.14
5.15

Stock price statisticsIndustry

52-Week High
$20.56
–
52-Week Low
$2.90
–
20-Day Moving Average
$4.86
–
50-Day Moving Average
$7.72
–
200-Day Moving Average
$11.80
–
Average True Range (14)
$0.48
–
Price Change (1 Week)
-36.5%
-1.15%
Price Change (1 Month)
-53.1%
-4.87%
Price Change (3 Months)
-76.2%
-21.0%
Price Change (6 Months)
-80.9%
-20.6%
Price Change (YTD)
-80.7%
-23.6%
Price Change (1 Year)
-83.0%
-22.4%
Price Change (3 Years)
-99.8%
-29.5%
Price Change (5 Years)
-100.0%
-77.9%
Price Change (10 Years)
-100.0%
-65.4%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
712,020
–
Relative Volume
2.77
0.70
Relative Strength Index (14)
11.5
43.4
Volatility (1 Year)
74.0%
80.1%
Beta (5 Years)
2.01
1.07

MarginsIndustry

Gross Margin
89.3%
53.1%
Operating Margin
-436.3%
-38.7%
Profit Margin
-420.4%
-31.6%
EBITDA Margin
-431.0%
-27.7%
FCF Margin
-395.0%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
-84.1%
-49.9%
Return on Assets (ROA)
-73.1%
-40.6%
Return on Invested Capital (ROIC)
-387.9%
-32.9%
Return on Capital Employed (ROCE)
-93.7%
-37.9%

Financial positionIndustry

Current Ratio
4.57
3.30
Quick Ratio
4.22
2.39

GrowthIndustry

Revenue Growth (YoY)
318.0%
6.82%

EfficiencyIndustry

Asset Turnover
0.17
0.40
Revenue Per Employee
$303.14K
$429.29K
Profits Per Employee
-$1.27M
-$689.41K
Employee Count
142
74
WACC
15.2%
10.2%

Income statement (TTM)Industry

Revenue
$43.05M
$66.37M
Gross Profit
$38.46M
$120.78M
Operating Income
-$187.79M
-$21.37M
Net Income
-$180.99M
-$22.35M
EBITDA
-$185.55M
-$17.21M
EPS (Diluted)
-$12.22
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$162.79M
$17.76M
Net Cash Per Share
$9.49
$0.80
Equity (Book Value)
$199.49M
$53.89M
Book Value Per Share
$11.63
$1.50
Tangible Book Value
$199.37M
$27.13M
Working Capital
$150.11M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$165.29M
-$12.38M
Capital Expenditures
-$4.76M
-$1.00M
Free Cash Flow
-$170.04M
-$18.21M
FCF Per Share
-$9.91
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-350.6%
-21.8%
FCF Yield
-329.4%
-9.44%
Buyback Yield
-288.0%
-0.76%
Shareholder Yield
-288.0%
0.00%

Scores and fair valueIndustry

Altman Z-Score
-6.62
0.23
Piotroski F-Score
6
4
Beneish M-Score
-2.42
-2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodTNXPS&P 500DifferenceTNXP per yearS&P 500 per year
1 month-50.9%-3.0%−47.9 pts
3 months-75.9%-2.8%−73.1 pts
Year to date-80.7%+11.5%−92.2 pts
1 year-81.4%+13.5%−94.8 pts
3 years-99.8%+77.7%−177.5 pts-87.4%+21.1%
5 years-100.0%+72.6%−172.6 pts-90.3%+11.5%
10 years-100.0%+308.2%−408.2 pts-84.0%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M TNXP shares were sold short on Oct 30, 2026, up 12.8% from the previous report, or 19.40% of the shares available to trade. At recent volumes it would take 4.1 days to buy them back. Over the last 20 sessions, 56.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,318,461+12.8%802,0024.1
Oct 15, 20262,940,708+0.1%1,218,9492.4
Sep 30, 20262,937,499+3.5%497,6905.9
Sep 15, 20262,838,419-8.5%348,8778.1
Aug 31, 20263,102,016-9.0%486,6626.4
Aug 14, 20263,408,130-5.4%490,6617.0
Jul 31, 20263,601,417+0.5%500,4297.2
Jul 15, 20263,584,541+0.1%495,9387.2
Jun 30, 20263,582,293+16.2%586,9076.1
Jun 15, 20263,081,836+7.5%615,3845.0
May 29, 20262,867,066+22.4%460,9366.2
May 15, 20262,342,643-10.2%461,1245.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?